Name of the Procedure:
HLA Class II Typing, Low Resolution (eg, Antigen Equivalents); HLA-DRB1/3/4/5 and -DQB1
Summary
HLA Class II typing is a laboratory test used to determine the specific variations in the HLA-DRB1/3/4/5 and -DQB1 genes. These genes are part of the human leukocyte antigen (HLA) system, which plays a critical role in the immune system. The low-resolution typing provides a broad categorization of these genes, equating the results to antigen equivalents.
Purpose
This procedure is used to:
- Identify compatibility for organ and bone marrow transplants
- Assist in diagnosing certain autoimmune conditions
- Provide information for disease risk assessment
Indications
HLA Class II typing is indicated for individuals who:
- Are potential organ or bone marrow transplant recipients or donors
- Have family members with autoimmune diseases
- Require detailed immune system profiling for medical management
Preparation
Preparation for HLA Class II typing typically includes:
- No fasting or medication adjustments are usually needed
- Informing your healthcare provider about any medications you are taking
- A simple blood draw, for which no special preparation is usually required
Procedure Description
- A healthcare professional draws a small sample of blood from a vein, usually in the arm.
- The blood sample is sent to a specialized laboratory for analysis.
- In the lab, DNA from the blood cells is extracted and amplified.
- The specific HLA genes (HLA-DRB1/3/4/5 and -DQB1) are identified using molecular techniques.
- The results are classified into broad categories known as antigen equivalents.
Duration
The blood draw itself takes about 10-15 minutes. Laboratory analysis typically takes several days to a few weeks, depending on the lab's workload.
Setting
The blood sample is usually collected in a healthcare setting such as:
- Hospital
- Outpatient clinic
- Medical laboratory
Personnel
The procedure typically involves:
- A phlebotomist or nurse to draw the blood
- Laboratory technicians and specialists to analyze the sample
Risks and Complications
The risks associated with the blood draw are minimal but can include:
- Bruising or soreness at the puncture site
- Slight risk of infection
- Rarely, dizziness or fainting
Benefits
- Helps ensure compatibility for organ and bone marrow transplantation, reducing the risk of rejection
- Assists in diagnosing and managing autoimmune diseases
- Provides essential genetic information for personalized medical care
Recovery
There is essentially no recovery time required after the blood draw. Patients can resume normal activities immediately.
Alternatives
- High-resolution HLA typing for more detailed genetic information
- Serological HLA testing, which identifies proteins rather than genes
- Other diagnostic tests applicable for autoimmune diseases or transplant compatibility
Patient Experience
During the procedure, patients may feel a slight pinch during the blood draw. Post-procedure, there may be minor soreness or bruising at the puncture site. Most patients experience no significant discomfort and do not require pain management.